Mahamaya Lifesciences Ltd 52 Week High
Mahamaya Lifesciences Ltd
NSE: MAHALIFE
YEARHIGH
Key Highlights
- The 52 Week HIGH of Mahamaya Lifesciences Ltd is ₹ 205.05 as of 04 Mar 26 .
Company Fundamentals for Mahamaya Lifesciences Ltd
Market Price of Mahamaya Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 04 Mar 2026 | 159 |
| 02 Mar 2026 | 163.5 |
| 27 Feb 2026 | 156.05 |
| 26 Feb 2026 | 160.55 |
| 25 Feb 2026 | 165.05 |
| 24 Feb 2026 | 172.1 |
| 20 Feb 2026 | 180.9 |
| 19 Feb 2026 | 177.1 |
| 18 Feb 2026 | 184.95 |
| 17 Feb 2026 | 188.2 |
Asset Value vs Market Value of Mahamaya Lifesciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Mahamaya Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Mahamaya Lifesciences Ltd
Historical Net Profit of Mahamaya Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Mahamaya Lifesciences Ltd
Mahamaya Lifesciences Ltd News Hub
Shares of Mahamaya Lifesciences list in MT Group
The equity shares of Mahamaya Lifesciences (Scrip Code: 544611) are listed effective 18 November 202
Read more
18 Nov 25
BSE SME Mahamaya Lifesciences debuts with a modest pulse
The scrip was listed at Rs 116, a premium of 1.75% over the initial public offer (IPO) price. The st
Read more
18 Nov 25
Mahamaya Lifesciences to announce Quarterly Result
Mahamaya Lifesciences will hold a meeting of the Board of Directors of the Company on 2 December 202
Read more
27 Nov 25
